Company Filing History:
Years Active: 2004
Title: Profile of Inventor André Galarneau
Introduction: André Galarneau is an accomplished inventor based in Ste-Julie, Canada. With a focus on innovative assay methods, he has made significant contributions to the field of protein interaction detection. His groundbreaking work in this area is exemplified by his unique patent related to protein fragment complementation assays.
Latest Patents: André Galarneau holds a patent for a "Protein fragment complementation assay (PCA) for the detection of protein-protein, protein-small molecule and protein nucleic acid interactions based on the E. coli TEM-1 β-Lactamase." This innovative assay method outlines a process that includes generating reporter molecule fragments linked to interacting domains, allowing for interaction of these domains, and subsequently detecting the activity of the reconstituted reporter molecule. This method is significant as it can react with penicillin- or cephalosporin-class substrates, facilitating advanced detection of various biological interactions.
Career Highlights: Galarneau is associated with Odyssey Thera Inc., where he continues to advance the field of protein interaction assays. His career is marked by a dedication to innovative research and development, aimed at providing powerful tools for scientific and medical research.
Collaborations: André Galarneau has collaborated with notable individuals in his field, including Stephen William Watson Michnick. These collaborations highlight the importance of teamwork in driving innovation and the development of new technologies.
Conclusion: André Galarneau represents the spirit of innovation as an inventor with a patented method that enhances our understanding of biological interactions. His work at Odyssey Thera Inc. and collaborations with fellow scientists underscore the significance of his contributions to research and development in protein assays.